Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan

被引：22
|
作者：
Richards, S
Umbreit, JN
Fanucchi, MP
Giblin, J
Khuri, F
机构：
[1] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA
来源：
SOUTHERN MEDICAL JOURNAL | 2003年 / 96卷 / 10期
关键词：
citalopram; irinotecan; rhabdomyolysis; selective serotonin reuptake inhibitors;
D O I：
10.1097/01.SMJ.0000084311.35864.D6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 74-year-old man was admitted with rhabdomyolysis after undergoing initial treatment for gastrointestinal cancer with irinotecan. The syndrome partially resolved after the discontinuation of all of his usual medications, including his chronic selective serotonin reuptake inhibitor (SSRI). The rhabdomyolysis was exacerbated upon reinitiation of the SSRI and disappeared when the SSRI was discontinued. The combination of irinotecan and SSRI resulted in potentially lethal rhabdomyolysis.
引用
收藏
页码：1031 / 1033
页数：3
相关论文
共 50 条
  • [1] Selective serotonin-reuptake inhibitor-induced movement disorders
    Gerber, PE
    Lynd, LD
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (06) : 692 - 698
  • [2] Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations
    Waldinger, MD
    Olivier, B
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1998, 13 : S27 - S33
  • [3] Selective Serotonin Reuptake Inhibitor-Induced Hyponatremia: Clinical Implications and Therapeutic Alternatives
    Varela Pinon, Maria
    Adan-Manes, Jaime
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (04) : 177 - 179
  • [4] Cardiac Toxicity in Selective Serotonin Reuptake Inhibitor Users
    Lusetti, Monia
    Licata, Manuela
    Silingardi, Enrico
    Bonetti, Luca Reggiani
    Palmiere, Cristian
    AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY, 2015, 36 (04) : 293 - 297
  • [5] Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder
    Wu, Eric Q.
    Yu, Andrew P.
    Lauzon, Veronique
    Ramakrishnan, Karthik
    Marynchenko, Maryna
    Ben-Hamadi, Rym
    Blum, Steven
    Erder, M. Haim
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (04) : 441 - 451
  • [6] An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram
    Markowitz, JS
    DeVane, CL
    Liston, HL
    Montgomery, SA
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 (06) : 329 - 333
  • [7] Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment
    van Geffen, Erica C. G.
    van Hulten, Rolf
    Bouvy, Marcel L.
    Egberts, Antoine C. G.
    Heerdink, Eibert R.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (02) : 218 - 225
  • [8] Selective serotonin reuptake inhibitor discontinuation syndrome: A review
    Tamam, L
    Ozpoyraz, N
    ADVANCES IN THERAPY, 2002, 19 (01) : 17 - 26
  • [9] Selective serotonin reuptake inhibitor discontinuation syndrome: A review
    Lut Tamam
    Nurgul Ozpoyraz
    Advances in Therapy, 2002, 19 : 17 - 26
  • [10] Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis
    Khanassov, Vladimir
    Hu, Jingyi
    Reeves, David
    van Marwijk, Harm
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2018, 33 (12) : 1688 - 1708
12345